TickerFacts.

BioMarin Pharmaceutical Inc (BMRN): Gross Profit

Revenue minus cost of revenue for the same annual period and currency, computed by TickerFacts from the filed figures. The issuer may report gross profit or margin on a different basis.

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2013-12-31, 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$2.50B
Year ended 2025-12-31
$2.59B
Trailing 12 months to 2026-06-30
+16.3%
3-year compound annual growth
2008-12-31: $243.98M2009-12-31: $258.75M2010-12-31: $305.98M2011-12-31: $357.33M2012-12-31: $408.89M2013-12-31: $460.09M2014-12-31: $627.02M2015-12-31: $737.89M2016-12-31: $907.23M2017-12-31: $1.07B2018-12-31: $1.18B2019-12-31: $1.34B2020-12-31: $1.34B2021-12-31: $1.38B2022-12-31: $1.59B2023-12-31: $1.89B2024-12-31: $2.27B2025-12-31: $2.50B$2.50B
2008-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$2.50B+10.1%2026-02-26, From 2025-01-01
2024-12-31$2.27B+20.5%2026-02-26, From 2024-01-01
2023-12-31$1.89B+18.5%2026-02-26, From 2023-01-01
2022-12-31$1.59Bn/c2025-02-24, From 2022-01-01
2021-12-31$1.38B+3.0%2024-02-26, From 2021-01-01
2020-12-31$1.34B-0.6%2023-02-27, From 2020-01-01
2019-12-31$1.34B+14.3%2022-02-25, From 2019-01-01
2018-12-31$1.18B+9.7%2021-02-26, From 2018-01-01
2017-12-31$1.07B+18.1%2020-02-27, From 2017-01-01
2016-12-31$907.23M+23.0%2019-02-28, From 2016-01-01
2015-12-31$737.89M+17.7%2018-02-26, From 2015-01-01
2014-12-31$627.02M+36.3%2017-02-27, From 2014-01-01
2013-12-31$460.09Mn/c2016-02-29, From 2013-01-01
2012-12-31$408.89M+14.4%2015-03-02, From 2012-01-01
2011-12-31$357.33M+16.8%2014-02-26, From 2011-01-01
2010-12-31$305.98M+18.3%2013-02-26, From 2010-01-01
2009-12-31$258.75M+6.1%2012-02-22, From 2009-01-01
2008-12-31$243.98Mn/a2011-02-24, From 2008-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
BioMarin Pharmaceutical Inc (BMRN)2025-12-31$2.50B+10.1%
United Therapeutics Corp (UTHR)2025-12-31$2.80B+9.0%
Amneal Pharmaceuticals, Inc. (AMRX)2025-12-31$1.11B+9.1%
Alnylam Pharmaceuticals, Inc. (ALNY)2025-12-31$3.04B+56.4%
Perrigo Co PLC (PRGO)2025-12-31$1.49B-3.1%
Elanco Animal Health Inc (ELAN)2025-12-31$2.59B+6.4%
BeOne Medicines Ltd. (ONC)2025-12-31$4.67B+45.3%
Organon & Co. (OGN)2025-12-31$3.31B-10.8%
Phibro Animal Health Corp (PAHC)2026-06-30$512.51M+28.1%

Compare BMRN, UTHR, AMRX, ALNY side by side · Screen every company in Pharmaceutical Preparations ↗